News
New ASX gold developers emerge as inflation eases and record gold prices draw attention to the "rivers of cash" their ...
The heavily pre-treated patients showed median progression-free survival of 29 months, which meant their tumours didn’t get bigger. Overall survival was 32 months, with a “manageable” safety profile.
The ASX wobbled as the Fed held its ground, ANZ slipped, Neuren raked in royalty cash, Orica shot up, and Pro Medicus locked ...
Home loans with longer interest-only periods, offering lower initial repayments, are appearing in Australia as housing costs climb.
Hillgrove Resources (ASX:HGO) is on track to hit its 14,000t production guidance, positioning it to reap the rewards of high copper prices.
The ASX has dipped this morning, tracking down 0.23pc. The ASX Gold and Tech indices are on the rise, despite a fall in gold prices overnight.
Latin America is a vital source of copper supply, but mines are ageing and grades depleting. These ASX explorers could make the next big find.
ASX Mining juniors are giving their investors a confidence boost by investing big bucks in exploration declines.
As part of a “strategy re-set” x-ray imaging house Micro-X has focused on medical applications, rather than security and defence uses.
Good morning! Here’s everything you need to know, and some things you don't, before the ASX flings open its doors and begins trading today.
Could Island Pharmaceutical’s ISLA-101 small molecule treatment be an answer to dengue fever? The US DoD is paying close attention.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results